Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Nrg Therapeutics Appoints Paul Thompson As Chief Development Officer

PRIVATEDec 05, 2025•6 months ago

Position

Chief Development Officer

Company

NRG Therapeutics

Paul Thompson

StevenageBiotechnologyHealth CareTherapeutics

Description

NRG Therapeutics has appointed Paul Thompson as its new Chief Development Officer, who brings specialist expertise in neurology to his new role. Thompson's experience includes translational research and early clinical development.

Company Information

Company

NRG Therapeutics

Location

Stevenage, England, United Kingdom

About

NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND).

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for NRG Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months